LO
ConstraintCognitive automation2026-03-24
The LungIMPACT randomised trial of 93,326 chest X-rays found AI worklist prioritisation had no significant effect on the lung cancer pathway; earlier gains came from immediate radiographer triage
Radiographer / radiologic technologistoccupation page →
Event date / reported
2026-03-24
Evidence stage
ConstraintFailure, rollback, regulation or cost is suppressing adoption. Can lower an assessment or widen its uncertainty.
Tasks this bears on
Acting on software that flags findings
Where a department uses software that flags a possible urgent finding as images are taken, making sure the flag reaches the right doctor in time and that the patient is not sent away first.
New task✓ Evidence-backed
Where this applies
A randomised trial across five NHS trusts: 93,326 chest X-rays requested by primary care were analysed, with AI prioritisation of the reporting worklist switched on or off by day, while the AI itself was applied at the time of image acquisition in both arms. AI prioritisation had no significant impact on the lung cancer pathway, and the authors conclude that chest X-ray AI deployments should not include worklist prioritisation in this context. They attribute the improvement in their earlier study to immediate radiographer triage, which the reporting-queue change did not reproduce. Peer-reviewed and open access; funded by SBRI Healthcare, with one author holding a travel grant from the AI vendor. It shows where a flag must be acted on to matter; it does not measure how many departments have radiographers act on flags at the scanner.
What this means
A flag from an AI reading chest X-rays did nothing when it only moved the image up a reporting queue; the gains came when a radiographer at the scanner acted on it straight away. Acting on the flag, in the room, is the part that matters.
What it does not yet show
It is one trial in one pathway in the NHS; it does not show how common radiographer triage at the scanner is, or whether it scales.
What you can check
Open the LungIMPACT trial in Nature Medicine and find "CXR AI deployments should not include worklist prioritization in this context".
Does it change the assessment?
No. The impact index is never moved by a single event. What this record did: the 1 linked task judgement above now rest on evidence instead of inference.
Source
Woznitza et al. — "AI-based chest X-ray prioritization in the lung cancer diagnostic pathway: the LungIMPACT randomized controlled trial", Nature Medicine (published 24 March 2026) · verified 2026-09-27 · Claude (VOLO agent) · interpreted 2026-09-27 · Claude (VOLO agent)
Primary source — published by the party that did this, or the authority of record. No co-signature needed.